Loading provider…
Loading provider…
Hematology & Oncology Physician in Dallas, TX
NPI: 1346333663Primary Practice Location
UT OF TEXAS SOUTHWESTERN UNIVERSITY HOSPITAL - WILLIAM P. CLEMENTS JR.
6201 Harry Hines Blvd, Dallas, TX
Primary Employer
University of Texas Southwestern Medical Center at Dallas
utswmed.org
HQ Phone
Get M.D. Suzanne's Phone Numberphone_androidMobile
Get M.D. Suzanne's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
2006 - 2025
OK State Medical License
2014 - 2019
WV State Medical License
2010 - 2016
ND State Medical License
2006 - 2006

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
University of Texas Health Science Center at Houston/M D Anderson Cancer Center
Fellowship • Hematology and Medical Oncology
2007 - 2010
University of Texas Southwestern Medical Center
Residency • Internal Medicine
2003 - 2006
UT Southwestern Medical Center
utsouthwestern.edu
Medical School
Until 2003
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 197 | 517 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 74 | 80 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 55 | 55 |
| 4 | 99443Physician telephone patient service, 21-30 minutes of medical discussion | 11 | 11 |
Differences in systemic immune parameters in individuals with lung cancer according to race.
Authors: Igor Puzanov, Montaser Shaheen, Sheena Bhalla, Gregory Daniels, David Gerber, Yousef Zakharia
Journal: bioRxiv
Publication Date: 2024-06-10
Authors: Davis, Rachel E, Dal Cin, Sonya, Cole, Suzanne M, Reyes, Ligia I, McKenney-Shubert, Shannon J, Fleischer, Nancy L, Densen, Lynna Chung, Peterson, Karen E
Journal: Health Commun
Publication Date: 2016-10-21
Authors: Natia Murvelashvili, Oksana Hamidi, Sarah Khorsand, Patricio Polanco, Sasan Mirfakhraee, Mouhammed Habra, Tobias Else
Journal: J Endocr Soc
Publication Date: 2022-06-29
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Nivolumab, DRUG: Pembrolizumab, DRUG: Atezolizumab, DRUG: Avelumab, DRUG: Durvalumab
Lead Sponsor: University of Texas Southwestern Medical Center
Intervention / Treatment: RADIATION: personalized ultrafractionated stereotactic ablative radiotherapy
Lead Sponsor: QED Therapeutics, Inc., a Bridgebio company
Collaborators: Helsinn Healthcare SA
Intervention / Treatment: DRUG: Placebo, DRUG: Infigratinib